Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Depression
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Depression
    Duloxetine, SSRIs Produce Similar Rates of Sexual Dysfunction in Patients With Depression: Presented at WCBP - (DGDispatch)
    TopAbstracts in Depression 07/01/2009 - (DGNews)
    Desvenlafaxine Reduces Anxiety Associated With Major Depressive Disorder: Presented at WCBP - (DGDispatch)
    Desvenlafaxine Is Effective for Major Depressive Disorder: Presented at WCBP - (DGDispatch)
    Armodafinil Improves Excessive Sleepiness Associated With Treated Obstructive Sleep Apnoea in Patients With Depression: Presented at ENS - (DGDispatch)

    News archive

     Recent webcasts/CME - Depression
      Treatment-Resistant Depression -- Part III: Switching Antidepressants vs. Conventional Augmentation Strategies
      On the Front Line of Major Depressive Disorder and Comorbidities: Managed Care and the Primary Care Physician
      Treatment-Resistant Depression -- Part II: Augmentation Strategies
      Treatment-Resistant Depression -- Part I: Introduction and Clinical Presentations
      Enhancing Treatment for Patients with Comorbid Depression, Diabetes and Heart Disease

      Webcasts/CME archive

       Recent cases - Depression
        Creutzfeldt-Jacob Disease Presenting as Severe Depression: A Case Report
        Sexual Dysfunction in a Young Mother
        Psychiatric Disorder Associated with Vacuum-Assisted Breast Biopsy Clip Placement: A Case Report
        A Postmenopausal Woman Presenting with Ekbom Syndrome Associated with Recurrent Depressive Disorder: A Case Report
        Affective Psychosis, Hashimoto's Thyroiditis, and Brain Perfusion Abnormalities: Case Report

        Cases archive
          




        my personal edition > depression > news
        divider

          E-Mail this DGReview to a colleague

        DGReview


        Patients with Delusional Depression May Be Less Likely to Relapse After Electroconvulsive Therapy

        A DGReview of :"One-Year Follow-Up After Successful ECT: A Naturalistic Study in Depressed Inpatients"
        Journal of Clinical Psychiatry

        02/11/2004
        By Jill Taylor


        The relapse rate up to 1 year after electroconvulsive therapy (ECT) may be lower for patients with delusional depression than in depressed patients without delusions, according to a new study.

        Treatment of severe depression with ECT is highly effective, although relapse rates within 1 year of ECT discontinuation may be greater than 50%. Furthermore, post-ECT pharmacotherapy does not appear to effectively reduce relapse rates.

        To examine the predictive value of pre-ECT pharmacotherapy and depression characteristics regarding post-ECT relapse, Tom K. Birkenhager, MD, of the Department of Psychiatry, Erasmus University Medical Centre, Rotterdam, the Netherlands, and colleagues studied 40 inpatients with major depression who responded to ECT.

        Among the subjects, 25 had delusional depression and 15 were depressed without delusions. Follow up for 1 year was performed prospectively for 28 patients and retrospectively for 12 patients. Relapse was defined as readmission, obvious decline in social functioning, or pharmacotherapy change due to worsening of depressive symptoms.

        Overall, 59% of depressed patients remained well while continuing pharmacotherapy, and all relapses occurred in the first 8 months of follow up. Due to the low number of patients receiving inadequate pharmacotherapy prior to ECT, data regarding the impact of adequate pre-ECT antidepressant trials on relapse was inconclusive.

        Surprisingly, the relapse rate in delusional patients was significantly lower than in non-delusional patients, at 6 months (12% vs. 53%, P = .03) and at 12 months (21% vs. 73%, P = .002) post-ECT.

        "Since our study is descriptive rather than predictive, or findings regarding the more favourable 1-year outcome in delusional depression need to be confirmed by larger fully prospective studies," the investigators concluded.

        J Clin Psychiatry 2004 Jan;65:1:87-91. "One-Year Follow-Up After Successful ECT: A Naturalistic Study in Depressed Inpatients"

        E-Mail this DGReview to a colleague   To print, use this version






        All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send